64Cu-PD-29875

N/A

Report date: 2025/11/20 16:03:44

NMEFirst In Class

Base Information

Drug Name64Cu-PD-29875

Drug Alias NameCopper[64Cu]-PD-2987564Cu-PD-29875

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Copper > 64CuRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionRadionuclide imaging enhancers

TargetsClaudin-18 splice variant 2

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPeptiDream Inc

China Registration ClassN/A

Develop Information

Active CompaniesPeptiDream Inc

Inactive CompaniesN/A

Active IndicationsPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A